SMH
CUE icon

Sanders Morris Harris’s Cue Biopharma CUE Stock Holding History

Sanders Morris Harris’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,540
Closed -$713K – 183
2023
Q3 		$713K Buy
11,540
+9,659
+514% +$943K 0.15% 106
2023
Q2 		$199K Buy
+1,881
New +$221K 0.04% 233
2023
Q1 		– Sell
-1,881
Closed -$161K – 173
2022
Q4 		$161K Sell
1,881
-26,387
-93% -$2.41M 0.06% 181
2022
Q3 		$2.02M Buy
28,268
+3,728
+15% +$321K 0.49% 31
2022
Q2 		$1.8M Sell
24,540
-4,561
-16% -$534K 0.39% 42
2022
Q1 		$4.26M Buy
29,101
+17,131
+143% +$3.63M 0.83% 23
2021
Q4 		$4.42M Buy
11,970
+1,779
+17% +$688K 0.76% 24
2021
Q3 		$4.1M Buy
10,191
+1,927
+23% +$672K 0.75% 25
2021
Q2 		$2.77M Sell
8,264
-3,487
-30% -$1.35M 0.54% 37
2021
Q1 		$4.38M Buy
11,751
+5,298
+82% +$2.18M 0.93% 24
2020
Q4 		$2.45M Buy
6,453
+1,705
+36% +$681K 0.56% 43
2020
Q3 		$2.31M Buy
+4,748
New +$2.74M 0.63% 38
2020
Q1 		– Sell
-2,325
Closed -$1.14M – 185
2019
Q4 		$1.14M Buy
+2,325
New +$730K 0.26% 97

Other funds holding CUE

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Sanders Morris Harris's CUE Position: Q4 2023 in Review

Sanders Morris Harris sold out of Cue Biopharma (CUE) in Q4 2023, closing a stake of 11,540 shares — an estimated $713K sold.

Sanders Morris Harris first reported a position in CUE in Q4 2019 and held it in 13 quarters. The position peaked at $4.42M in Q4 2021. 80 funds tracked by Wall St. Rank hold CUE as of Q4 2023.

  • Sanders Morris Harris reported no remaining Cue Biopharma position as of Q4 2023 after selling out during the quarter.
  • Sanders Morris Harris sold 11,540 Cue Biopharma shares in Q4 2023, an estimated $713K.
  • Sanders Morris Harris first reported a position in Cue Biopharma in Q4 2019 and held it in 13 quarters.
  • Sanders Morris Harris's Cue Biopharma position peaked at $4.42M in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Cue Biopharma as of Q4 2023.

Based on Sanders Morris Harris's 13F filing for Q4 2023, filed 10 Jan 2024.